Hookipa Pharma
IPO News: Filed S-1/A: Hookipa Pharma Launches 6.67mm Share IPO with $14.00 - $16.00 Marketing Range
Hookipa Pharma

Hookipa Pharma


Initial Filing Date: 03/22/19

Launch Date: 04/08/19

Price Range: $14.00 - $16.00

Shares Offered (Pre-Shoe | mm): 6.7

Primary Shares (mm):      6.7

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $100.1

% Secondary: 0.0%

Shares Outstanding (mm): 26.1

Market Value at Midpoint (mm): $391.1

Offering as % of Market Value:    25.6%

Bookrunners: BAML | LEER | RBC

Co-Managers: Kempen

Major Holders:   Baker Bros. Advisors | Sofinnova Capital | Forbion Capital Fund | Boehringer Ingelheim Venture Fund | Takeda Ventures | HBM BioCapital | Redmile Group

Industry: Healthcare

Description: Hookipa Pharma is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics targeting infectious diseases and cancers based on their proprietary arenavirus platform that is designed to reprogram the body's immune system.

Note: Emerging Growth Company

Launch Link: S-1/A